创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Recent Advances in Direct-acting Antivirals for the Treatment of Hepatitis C
LU Jie, XIE Qing
2018, 42(5): 323-327.
Abstract PDF
Research Progress in New Drugs for Antiviral Treatment of Chronic Hepatitis B
REN Hong
2018, 42(5): 328-332.
Abstract PDF
Recent Progress in Therapeutic Drugs of Autoimmune Liver Diseases
YAN Li, MA Xiong
2018, 42(5): 333-336.
Abstract PDF
2017 Annual Report on Drug Registration in Jiangsu Province
WANG Zongmin, DING Guirong
2018, 42(5): 337-340.
Abstract PDF
2017 Report on the Development of Jiangsu Pharmaceutical Industry
CHU Shuzhen, CHEN Yi, XU Fangping
2018, 42(5): 341-350.
Abstract PDF
Classification and Research Progress of Targeted Anti-tumor Drugs
YE Jiadan, YU Kefu, ZHU Bin, SI Yanbin, ZHAO Zhigang
2018, 42(5): 351-358.
Abstract PDF
Role of Epigenetic Modification in Metabolic Memory of Diabetic Vascular Disease
XIE Linjun, ZHEN Yunsi, HE Hua, LIU Xiaoquan
2018, 42(5): 359-365.
Abstract PDF
Research Advances in Tumor Microenvironment Responsive Polymeric Nano-drug Delivery System
ZHANG Yu, YIN Shaoping, XU Jianan, LI Juan
2018, 42(5): 366-374.
Abstract PDF
Advances in the Research of Radio-responsive Chemotherapeutic Drug Delivery Systems for Anticancer Therapy
WEN Yajing, ZHANG Can, JU Caoyun
2018, 42(5): 375-379.
Abstract PDF
Research Progress in Liposome-in-natural Polymer Hydrogel Drug Delivery Systems
ZHU Haocheng, LUAN Libiao
2018, 42(5): 380-387.
Abstract PDF
Progress in Pharmacokinetics of Progesterone and Its Derivatives
XU Congxuan, YING Minghua, XU Cheng, ZHOU Jianshe, YAO Jing
2018, 42(5): 388-393.
Abstract PDF
A Report of New Drugs Research and Development in 2017—Part Ⅰ: New Drugs & Biologics (Ⅱ)
Graul A I, Pina P, Stringer M
2018, 42(5): 394-398.
Abstract PDF
An Overview of New Drugs Approved in the US and EU in April 2018
SUN Yousong
2018, 42(5): 399-400.
Abstract PDF